The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
Jiwon Oh(St. Michael's Hospital), V. Wee Yong(University of Calgary), Shannon Kolind(University of British Columbia), Scott B. Patten(University of Calgary), Anthony Traboulsee(University of British Columbia), Melanie Guenette(Mount Sinai Hospital), Alexandre Prat(Université de Montréal), Fabrizio Giuliani(University of Alberta), Larry D. Lynd(Providence Health Care), Roger Tam(Allen Institute for Brain Science), Luanne M. Metz(Foothills Medical Centre), Ruth Ann Marrie(University of Manitoba), Penelope Smyth(University of Alberta), Alice Schabas(University of British Columbia), Nathalie Arbour(Centre Hospitalier de l’Université de Montréal)
Cited by 17
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
The Blood–Brain Barrier
|Cold Spring Harbor Perspectives in Biology|2015|3.2k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k